e-ESO Podcasts

143 Episoder

1. Immunotherapy rechallenge in NSCLC

   Publisert: 3.3.2022
2. ESO’s career development programme

   Publisert: 24.2.2022
3. Summary/Review - Reporting Guidelines - CONSORT

   Publisert: 17.2.2022
4. Summary/Review: Long-term results of SNB after NCT for primary cN1/2 breast who convert to cN0

   Publisert: 10.2.2022
5. Summary/Review: Pathology after neoadjuvant treatment for breast cancer – How to assess residual disease.

   Publisert: 3.2.2022
6. Intraoperative breast ultrasound

   Publisert: 27.1.2022
7. Summary/Review - Reporting Guidelines - PRISMA 2020

   Publisert: 20.1.2022
8. Summary/Review - The use of Artificial Intelligence in the Oncology field. Addressing all the hype and skepticism.

   Publisert: 13.1.2022
9. Advanced Gastric Cancer

   Publisert: 9.12.2021
10. PARP inhibitors for the treatment of ovarian cancer

    Publisert: 2.12.2021
11. The role of clinician-scientists in modern oncology

    Publisert: 25.11.2021
12. Pharmacologic interactions with new drugs

    Publisert: 18.11.2021
13. Positive Resection Margins in Colon Cancer

    Publisert: 11.11.2021
14. Immunotherapy in Lung Cancer

    Publisert: 4.11.2021
15. Low HR positive breast cancer

    Publisert: 28.10.2021
16. Possibilities of tackling side effects of cancer therapies

    Publisert: 21.10.2021
17. Fertility preservation in young cancer patients

    Publisert: 14.10.2021
18. CDK4/6i in HR+HER2- breast cancer

    Publisert: 7.10.2021
19. Treatment selection in castration-resistant prostate cancer

    Publisert: 30.9.2021
20. Questions and Controversies in Localized Head and Neck Cancer

    Publisert: 23.9.2021